mRNA-Based Vaccine Designing against Epstein-Barr Virus to Induce an Immune Response Using Immunoinformatic and Molecular Modelling Approaches

Epstein-Barr Virus (EBV) is a human pathogen that has a morbidity rate of 90% in adults worldwide. Infectious mononucleosis is caused by EBV replication in B cells and epithelial cells of the host. EBV has also been related to autoimmune illnesses, including multiple sclerosis and cancers like nasop...

Descripción completa

Detalles Bibliográficos
Autores principales: Althurwi, Hassan N., Alharthy, Khalid M., Albaqami, Faisal F., Altharawi, Ali, Javed, Muhammad Rizwan, Muhseen, Ziyad Tariq, Tahir ul Qamar, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602923/
https://www.ncbi.nlm.nih.gov/pubmed/36293632
http://dx.doi.org/10.3390/ijerph192013054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602923/
https://www.ncbi.nlm.nih.gov/pubmed/36293632
http://dx.doi.org/10.3390/ijerph192013054

Ejemplares similares